HIV Drugs: Trigger of Autoimmunity

Implicit, severe immune sensitive reactions to the anti-HIV drug abacavir materialize through an autoimmune procedure, resulting from the design of drug-induced immunizing agent that are attacked by the body's immune system as all HIV Drugs blocks protein synthesis and enzymes which cause alteration in and enzyme synthesis, autoimmune deformities accrue in HIV Patient and proteins. Many times foreign myalgia’s and arthralgia’s occur in about 5% of patients with HIV, sometimes in association with HIV seroconversion.  Many bone related diseases and HIV-associated arthralgia started progresses towards inflammatory joint disease and disorders because of HIV Treatment.

    Related Conference of HIV Drugs: Trigger of Autoimmunity

    October 19-20, 2018

    10th World Congress and Expo on Immunology

    New York, USA
    October 29-30, 2018

    6th International Conference on HIV/AIDS, STDs and STIs

    San Francisco, USA
    November 26-27, 2018

    3rd International Conference on Autoimmunity

    Dublin, Ireland (Louis Fitzgerald Hotel)
    December 05-06, 2018

    Global Meet on Immunology, Hematology and Molecular Biology

    Portugal, Lisbon
    December 06-08, 2018

    Annual Congress on Antibiotics and Antimicrobial Resistance

    Amsterdam, Netherlands
    March 04-05, 2019

    10th Molecular Immunology & Immunogenetics Congress

    Barcelona, Spain
    March 18-19, 2019

    11th Global Summit on Immunology and Cell Biology

    Sydney, Australia
    June 13-14, 2019 |

    10th European Immunology Conference

    Berlin, Germany
    July 29-30 2019

    6th International Conference on Parasitology & Microbiology

    Amsterdam, Netherlands
    November 22-23, 2019 |

    World Conference on Vaccine and Immunology

    Dubai, UAE

    HIV Drugs: Trigger of Autoimmunity Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in